CD8A and neoplasm: Along these lines, at least a subset of patients that undergo PD-1 blockade for tumor treatment and develop neurological side effects, have recently been shown to harbor elevated EBV loads and accumulate EBV infected B cells and EBV reactive CD4+ and CD8+ T cells in their central nervous system (65).